VLI's Today contraceptive sponge
Executive Summary
FDA Office of Epidemiology & Biostatistics Director Gerald Faich, MD, et al, reported in the Jan. 10 issue of the Journal of the American Medical Assn. that there has been an incidence of 13 cases of sponge-related toxic shock syndrome (TSS) from the time the drug was launched in July 1983 through Nov. 1, 1984. During that time, they note that 20 mil. sponges were distributed. The authors conclude that while the risk of TSS is elevated with sponge use, "it still represents a small risk." They report that "to date about one case (without predisposing factors and occurring within 48 hours of use) per 2 million sponges used has been reported".
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.